Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Thrombosis Research|June 30, 2007
Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplastyLars C Borris, Morten Breindahl, Camilla Ryge, et al.Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.Journal of the Southern Orthopaedic Association|February 25, 2003
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgeryAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.Journal of the American College of Cardiology|April 12, 2008
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) studyMichael R Lassen, Ola Dahl, Patrick Mismetti, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 21, 2012
Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparinJustin W Griffin, William J Hopkinson, Michael R Lassen, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2015
Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical PracticeMichael R Lassen, Sylvia Haas, Reinhold Kreutz, et al.British Journal of Clinical Pharmacology|November 19, 2015
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactionsReinhold Kreutz, Sylvia Haas, Gerlind Holberg, et al.Vascular Health and Risk Management|June 16, 2012
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgeryAlexander G G Turpie, André C Schmidt, Reinhold Kreutz, et al.Chest|July 24, 2008
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)William H Geerts, David Bergqvist, Graham F Pineo, et al.Pageof 4